Background illustration for clinical trials search

Paid Clinical Trials Allentown

Discover 2,122 paid clinical trials in Allentown, Pennsylvania. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy

for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Philadelphia PA, New York NY, Washington D.C. DC,
Sponsor: Children's Oncology Group

Sex: All

Age: 1 - 18

Code: NCT06247787

Phase 1, Recruiting

Longitudinal Study of Urea Cycle Disorders

for
Brain Diseases, Metabolic, Inborn,
Location: Philadelphia PA, New York NY, Washington DC, Boston MA,
Sponsor: Andrea Gropman

Sex: All

Age: 0+

Code: NCT00237315

Recruiting

52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism

for
Hypogonadism, Male
Location: Philadelphia PA, The Bronx NY, Worcester MA, Boston MA,
Sponsor: Halozyme Therapeutics

Sex: Male

Age: 12 - 17

Code: NCT06689085

Phase 3, Recruiting

A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)

for
Malignant Neoplasm
Location: Philadelphia PA, New Brunswick NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 17

Code: NCT06941272

Phase 1, Phase 2, Recruiting

Phase 1/2: CD45RA Depleted Stem Cell Addback to Prevent Viral or Fungal Infections Post TCRab/CD19 Depleted HSCT

for
Leukemia, High Risk Acute Lymphoblastic Leukemia,
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 25

Code: NCT06839456

Phase 1, Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
New

Physiology-directed Epinephrine Dosing in Pediatric Cardiac Arrest

for
Cardiac Arrest (CA)
Location: Philadelphia PA, Wilmington DE, New York NY,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT07890610

Recruiting

Improving Mood for Adolescents Through Teaming With End-Users in Routine Care (The iMATTER Project)

for
Depressive Symptoms
Location: Philadelphia PA
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 13 - 17

Code: NCT07020572

Recruiting

A Study of Emapalumab for Pediatric Aplastic Anemia

for
Aplastic Anemia, Cytopenia, Hypocellular Marrow
Location: Philadelphia PA, New York NY, Richmond VA,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 0 - 25

Code: NCT06430788

Phase 2, Recruiting

Clinical and Biomarker Effects of Depot Medroxyprogesterone Acetate in Females With Sickle Cell Disease

for
Sickle Cell Disease (SCD),
Location: Philadelphia PA
Sponsor: University of Pennsylvania

Sex: Female

Age: 18 - 50

Code: NCT06665997

Recruiting

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

for
Overweight, Obesity
Location: Warren Township NJ, Eatontown NJ, Long Island City NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07282600

Phase 3, Recruiting

First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors

for
Neoplasms
Location: Philadelphia PA, Toronto, Montreal, San Antonio TX
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07438782

Phase 1, Recruiting

A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes

for
Type 1 Diabetes Mellitus
Location: Philadelphia PA, New York NY, New Haven CT, Buffalo NY,
Sponsor: Sanofi

Sex: All

Age: 1 - 25

Code: NCT07088068

Phase 3, Recruiting

Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults

for
Prurigo Nodularis
Location: Philadelphia PA, New York NY, Mount Kisco NY,
Sponsor: Galderma R&D

Sex: All

Age: 18+

Code: NCT06988618

Recruiting

A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors

for
Neoplasms
Location: Philadelphia PA, New Hyde Park NY, Ottawa, Toronto,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07277270

Phase 1, Recruiting

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

for
Ulcerative Colitis, Obesity or Overweight
Location: Philadelphia PA, New York NY, Yonkers NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937086

Phase 3, Recruiting

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

for
Crohn's Disease, Obesity or Overweight
Location: Philadelphia PA, New York NY, Yonkers NY,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18 - 70

Code: NCT06937099

Phase 3, Recruiting

A Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)

for
Connective Tissue Diseases
Location: Philadelphia PA, New York NY, Los Angeles CA
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT06716606

Phase 3, Recruiting

Zelenectide Pevedotin in NECTIN4 Amplified Advanced or Metastatic Non-small Cell Lung Cancer

for
Non-Small Cell Lung Cancer
Location: Philadelphia PA, Arlington VA, Boston MA, Fairfield OH,
Sponsor: BicycleTx Limited

Sex: All

Age: 18+

Code: NCT06933329

Phase 2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Philadelphia PA, New York NY, New Hyde Park NY,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase 3, Recruiting

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

for
Systemic Sclerosis Associated Interstitial Lung Disease,
Location: Philadelphia PA, New York NY, Baltimore MD,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05878717

Phase 2, Phase 3, Recruiting